---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-24-007944"
form_type: "8-K"
ticker: "VNRX"
cik: "0000093314"
company_name: "VOLITIONRX LTD"
filed_at: "2024-12-09T23:59:59+00:00"
generated_at: "2026-05-29T06:03:44.131871+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# VolitionRx raises up to $1.9M in registered direct offering with warrants for additional $2.7M

## Summary
- Offering includes 445,648 Insider Shares at $0.5722 and 2,857,389 shares with warrants at $0.5722.
- Form A warrants exercisable at $0.5722/share, Form B at $0.71525/share, both expire Dec 2029.
- Gross proceeds upfront ~$1.9M; potential additional $2.7M if warrants fully exercised.
- Proceeds for R&D, clinical studies, product commercialization, and working capital.
- Insiders participate; no placement agent; closing expected on Dec 9, 2024.

## SEC filing metadata
- accession: 0001477932-24-007944
- form_type: 8-K
- ticker: VNRX
- cik: 0000093314
- company_name: VOLITIONRX LTD
- filed_at: 2024-12-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/93314/000147793224007944/0001477932-24-007944-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/93314/000147793224007944/vnrx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-24-007944
- JSON: https://secwatch.observer/filing/0001477932-24-007944.json
- Plain text: https://secwatch.observer/filing/0001477932-24-007944.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.